Does SIMVASTATIN Cause Hyperlipidaemia? 97 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Hyperlipidaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.4% of all adverse event reports for SIMVASTATIN.
97
Reports of Hyperlipidaemia with SIMVASTATIN
0.4%
of all SIMVASTATIN reports
59
Deaths
71
Hospitalizations
How Dangerous Is Hyperlipidaemia From SIMVASTATIN?
Of the 97 reports, 59 (60.8%) resulted in death, 71 (73.2%) required hospitalization, and 59 (60.8%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which SIMVASTATIN Alternatives Have Lower Hyperlipidaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS